Trxade Health (Trxade Health) Interest Expense : $-1.20 Mil (TTM As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Trxade Health Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Trxade Health's interest expense for the three months ended in Dec. 2023 was $ -0.70 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.20 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Trxade Health's Operating Income for the three months ended in Dec. 2023 was $ -6.19 Mil. Trxade Health's Interest Expense for the three months ended in Dec. 2023 was $ -0.70 Mil. Trxade Health did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Trxade Health Interest Expense Historical Data

The historical data trend for Trxade Health's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trxade Health Interest Expense Chart

Trxade Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.05

-0.03

-0.02

-0.34

-1.20

Trxade Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-0.20	-0.06	-0.18	-0.25	-0.70

Trxade Health Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.20 Mil.

Trxade Health (NAS:MEDS) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Trxade Health's Interest Expense for the three months ended in Dec. 2023 was $-0.70 Mil. Its Operating Income for the three months ended in Dec. 2023 was $-6.19 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $0.43 Mil.

Trxade Health's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Trxade Health did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Trxade Health (Trxade Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Trxade Health Inc (NAS:MEDS) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2420 Brunello Trace., Lutz, FL, USA, 33558

Website

https://www.rx.trxade.com

Trxade Health Inc is a health service IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. Its product and services include Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC, Delivmeds.com, Bonum Health Hub and Application, and others. its business is classified into reportable segments which are Trxade, Inc, Community Specialty Pharmacy, LLC, Integra Pharma, LLC, and Other, and the majority of the revenue comes from Trxade, Inc.

Executives

A. Jeffrey Newell	director	645 CAMP DIXIE RD, PASCOAG RI 02859
Donald G. Fell	director	17537 DARBY LANE, LUTZ FL 33558
Janet Huffman	officer: CFO, PAO, PFO	5317 FRUITVILLE RD SUITE 6, SARASOTA FL 34232
Michael L Peterson	director	17 CANARY COURT, DANVILLE CA 94526
Christine L. Jennings	director	3840 LAND O' LAKES BLVD., LAND O' LAKES FL 34639
Prashant Patel	director, 10 percent owner, officer: President	17537 DARBY LANE, LUTZ FL 33558
Pamela Tenaerts	director	PO BOX 15012, SARASOTA FL 34277
Gary Augusta	director	700 NORTH BRAND BLVD., SUITE 1400, GLENDALE CA 91203
Howard A. Doss	officer: CFO	17537 DARBY LANE, LUTZ FL 90067
Surendra K Ajjarapu	director, 10 percent owner, officer: CEO	8604 BUTTON BUSH CT, TAMPA FL 33647
Donald V. Almeida	director	1115 GUNN HIGHWAY, SUITE 202, ODESSA FL 33556
Charles L Pope	director	4902 EISENHOWER BOULEVARD, TAMPA FL 33634
Sandhya Ajjarapu	10 percent owner	17537 DARBY LANE, LUTZ FL 33558